EZH2 and neoplasm: Numerous reports indicate the involvement of EZH2 in regulation of tumor microenvironment (TME) and antitumor immune response, which directly affect immunotherapy efficacy (Fratta et al., 2013; Tiffen et al., 2016b; Kim et al., 2020; Sun et al., 2022).